The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
J Neuropsychiatry Clin Neurosci 19:391-398, November 2007
doi: 10.1176/appi.neuropsych.19.4.391
© 2007 American Neuropsychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by LaFrance, W. C.
* Articles by Keitner, G. I.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by LaFrance, W. C., Jr.
* Articles by Keitner, G. I.
Related Collections
* Epilepsy
* Research Design, Methodology

Methodological Issues in Conducting Treatment Trials for Psychological Nonepileptic Seizures

W. Curt LaFrance, Jr., M.D., M.P.H., Andrew S. Blum, M.D., Ph.D., Ivan W. Miller, Ph.D., Christine E. Ryan, Ph.D. and Gabor I. Keitner, M.D.

Received July 21, 2005; revised July 7, 2006; accepted November 6, 2006. Drs. LaFrance and Blum are affiliated with the Department of Neurology and the Comprehensive Epilepsy Program, Brown Medical School, Providence, Rhode Island. Drs. LaFrance, Miller, Ryan, and Keitner are affiliated with the Department of Psychiatry and Human Behavior, Brown Medical School, Providence, Rhode Island. Address correspondence to Dr. LaFrance, Rhode Island Hospital, 593 Eddy Street, Potter 3, Neuropsychiatry, Providence, RI 02903; William_LaFrance_Jr{at}Brown.edu (e-mail).

A randomized, placebo-controlled trial has yet to be completed in patients with psychological nonepileptic seizures (NES). Treatment publications for NES are limited to class III trials and class IV reports. Little is written on the methodology of treatment trials in NES. The authors describe the procedures and limitations of such a trial to inform future NES treatment trials, based on their prospective, open-label pharmacological, feasibility trial. The authors review the recruitment, enrollment, completion of surveys, compliance, and follow-up of patients with NES. The majority of patients who enrolled, readily completed surveys and took the medication during the trial. Twelve patients were screened, eight enrolled, and six completed the trial. The authors discuss the use of outcomes and the various symptoms scales in the trial. A comprehensive neuropsychiatric initial assessment and assessing cognitive, emotional, behavioral, and psychosocial measures are important for monitoring the outcomes in NES treatment RCTs.







Get information about faster international access.

Privacy Policy

Copyright © 2007 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org